Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiwan Biotech Co., Ltd. ("TBC") is the first local pharmaceutical company established in Taiwan in 1945. It operates five main manufacturing plants across the country and offers nearly 500 products globally. The company specializes primarily in high-quality generic pharmaceuticals across multiple therapeutic areas including cardiovascular disease, CNS disorders, diabetes/metabolic conditions, respiratory illnesses, and ophthalmology. TBC has a strong international presence with business development divisions targeting Japan, Southeast Asia, Mainland China and North America. Its R&D includes both generics and innovative formulations such as transdermal patches for drugs like albuterol. The company holds PIC/S GMP certification for its facilities.[2][3][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan Biotech Foundation.